Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Donald Notman

COO at Ocular Therapeutix, Inc (OCUL)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $216K

Reported trades

Filed Stock Type Shares Price Value Since
Sep 2SEC OCULOcular Therapeutix, Inc Sell 1,099366,529 held (−0%) $10.24 $11K -32.9%
Feb 17SEC OCULOcular Therapeutix, Inc Sell 11,446366,356 held (−3%) $9.04 $103K -24.0%
Feb 4SEC OCULOcular Therapeutix, Inc Sell 5,455383,837 held (−1%) $9.14 $50K -24.8%
Feb 4SEC OCULOcular Therapeutix, Inc Sell 6,035377,802 held (−2%) $8.54 $52K -19.6%